CXR102

N/A

Report date: 2025/12/12 15:29:16

Base Information

Drug NameCXR102
Drug Alias NameCXR-102CXR102
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 modulators
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorriXR Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesCorriXR Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A